Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

NCT00212732 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

750

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: ONO-8025 (KRP-197)

Sponsor

Ono Pharmaceutical Co., Ltd.